France approves Johnson & Johnson's Janssen COVID-19 vaccine


  • World
  • Saturday, 13 Mar 2021

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration//File Photo

PARIS (Reuters) - France's health regulator said on Friday it had approved Johnson & Johnson's single-dose COVID-19 vaccine for use in France, a day after it was approved by the European Union authorities.

"The COVID-19 Janssen vaccine can be used on people from the age of 18 ... within the framework of the French vaccination strategy, including for people aged 65 and older and who might have illnesses," the Haute Autorite de Sante (HAS) said in a statement.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Judge to consider gag order violations in Trump hush money trial
Azerbaijan asks World Court to move forward with Armenia discrimination case
TikTok risks fines as EU issues ultimatum over app launch
TikTok’s crackdown on Ozempic influencers threatens weight-loss drug hype machine
Russia's Belgorod region says 120 civilians killed by Ukraine strikes since 2022
Migrants drown in Channel, Sunak says nothing will stop Rwanda policy
Tesla layoffs draw suit claiming not enough warning for workers
Truce crumbles in Sudanese army's last Darfur holdout
Report urges fixes to online child exploitation CyberTipline before AI makes it worse
Indonesia's biggest party confirms President Jokowi no longer a member after backing Prabowo

Others Also Read